Results for tag: "Kaposi Sarcoma Drug"

Kaposi Sarcoma (KS) is a type of cancer that affects the skin and other organs. It is caused by the human herpesvirus 8 (HHV-8). Treatment for KS typically involves chemotherapy, radiation therapy, and/or biologic therapy. Oncology drugs are used to treat KS, and the Kaposi Sarcoma Drug market is a subset of the larger Oncology Drug market. The Kaposi Sarcoma Drug market is composed of drugs used to treat KS, including chemotherapy drugs, biologic therapies, and other treatments. These drugs are used to reduce the size of tumors, reduce symptoms, and improve quality of life. The market is highly competitive, with many companies offering different treatments. Some companies in the Kaposi Sarcoma Drug market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies offer a variety of treatments for KS, including chemotherapy drugs, biologic therapies, and other treatments. Show Less Read more